Even though the role of MMP‐2 remains undisputed in cardiovascular disease [5, 22, 23] it appears to be more relevant as a predictor of long-term outcomes whereas MMP‐9 has been more frequently reported in (sub)acute systemic responses following cardiac and non-cardiac events [34, 35], which is in line with our findings. This evidence concerns the gene MMP9 and cardiovascular disorder.